Literature DB >> 29323538

Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review.

Ran Wang1,2, Xingshun Qi1, Eric M Yoshida3, Nahum Méndez-Sánchez4, Rolf Teschke5, Mingyu Sun6, Xu Liu1, Chunping Su7, Jiao Deng8, Han Deng1, Feifei Hou1, Xiaozhong Guo1,2.   

Abstract

BACKGROUNDS: Traditional Chinese medicine (TCM) is becoming increasingly popular and related adverse events are often ignored or underestimated. AIMS: This systematic review aimed to evaluate the clinical characteristics and outcomes of TCM-induced liver injury (TCM-ILI) and to estimate the proportion of TCM-ILI in all drug-induced liver injuries (DILI).
METHODS: China National Knowledge Infrastructure, Wanfang, VIP, PubMed, and Embase databases were searched. Demographic, clinical, and survival data were extracted and pooled. Factors associated with worse outcomes were calculated. For the proportion meta-analyses, the data were pooled by using a random-effects model.
RESULTS: Overall, 21,027 articles were retrieved, of which 625 were finally included. There was a predominance of female and older patients. The proportion of liver transplantation was 2.18% (7/321). The mortality was 4.67% (15/321). Male, higher aspartate aminotransferase and direct bilirubin, and lower albumin were significantly associated with an increased risk of death/liver transplantation in TCM-ILI patients. The proportion of TCM-ILI in all DILI was 25.71%. The proportion was gradually increased with year.
CONCLUSIONS: Our work summarises current knowledge regarding clinical presentation, disease course, and prognosis of TCM-ILI. TCM can result in hepatotoxicity, even death or necessitate life-saving liver transplantation. Governmental regulation of TCM products should be strictly established.

Entities:  

Keywords:  ALP; ALT; CNKI; China National Knowledge Infrastructure; DILI; RUCAM; Roussel Uclaf Causality Assessment Method; SD; TCM; TCM-ILI; TCM-induced liver injury; ULN; alanine aminotransferase; alkaline phosphatase; drug-induced liver injury; standard deviation; traditional Chinese medicine; upper limit of normal

Mesh:

Substances:

Year:  2018        PMID: 29323538     DOI: 10.1080/17474124.2018.1427581

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  10 in total

Review 1.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

2.  Alternative medicine products causing acute liver injury: Pandora's box is open.

Authors:  Fanny Bergeron; Trana Hussaini; Natasha Chandok; Eric M Yoshida
Journal:  Can Liver J       Date:  2019-05-22

3.  Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Authors:  Zhibin Zhang; Sisi Li; Zhixiong Zhang; Kaihui Yu; Xunxin Duan; Lin Long; Shulan Zhang; Meiying Jiang; Ougen Liu
Journal:  Indian J Dermatol       Date:  2020 Jul-Aug       Impact factor: 1.494

4.  Fraxinellone Induces Hepatotoxicity in Zebrafish through Oxidative Stress and the Transporters Pathway.

Authors:  Shuting Wang; Jie Bao; Jie Li; Wanfang Li; Mengyin Tian; Caixia Qiu; Fei Pang; Xin Li; Jianbo Yang; Yuchi Hu; Sujuan Wang; Hongtao Jin
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

Review 5.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

Review 6.  Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia.

Authors:  Cyriac Abby Philips; Philip Augustine; Sasidharan Rajesh; Praveen Kumar Y; Deepak Madhu
Journal:  J Clin Transl Hepatol       Date:  2019-09-02

7.  Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods.

Authors:  Hongyi Yang; Daihong Guo; Yuanjie Xu; Man Zhu; Chong Yao; Chao Chen; Wangping Jia
Journal:  Front Pharmacol       Date:  2019-07-19       Impact factor: 5.810

8.  Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase.

Authors:  Florence van Hunsel; Sonja van de Koppel; Souad Skalli; Andrea Kuemmerle; Lida Teng; Jia-Bo Wang; Joanne Barnes
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

Review 9.  Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.

Authors:  Rolf Teschke; Axel Eickhoff; Amy C Brown; Manuela G Neuman; Johannes Schulze
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

Review 10.  Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).

Authors:  Rolf Teschke; Gaby Danan
Journal:  Diagnostics (Basel)       Date:  2021-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.